Search

This study employs an optimized and environmentally friendly method to extract and purify chondroitin sulfate (CS) from bovine nasal cartilage using enzymatic hydrolysis, ethanol precipitation, and DEAE Sepharose Fast Flow column chromatography. The extracted CS, representing 44.67 % ± 0.0016 of the cartilage, has a molecular weight of 7.62 kDa. Characterization through UV, FT-IR, NMR spectroscopy, and 2-aminoacridone derivatization HPLC revealed a high content of sulfated disaccharides, particularly ΔDi4S (73.59 %) and ΔDi6S (20.61 %). Interaction studies with bovine serum albumin (BSA) using fluorescence spectroscopy and molecular docking confirmed a high-affinity, static quenching interaction with a single binding site, primarily mediated by van der Waals forces and hydrogen bonding. The interaction did not significantly alter the polarity or hydrophobicity of BSA aromatic amino acids. These findings provide a strong foundation for exploring the application of CS in tissue engineering and drug delivery systems, leveraging its unique interaction with BSA for targeted delivery and enhanced efficacy., Competing Interests: Declaration of competing interest The materials discussed herein have not been published elsewhere before, and the manuscript has not been submitted to any other journals., (Copyright © 2024. Published by Elsevier B.V.)

Pulmonary hypertension is a pathophysiologic manifestation of a heterogeneous group of diseases, with the main pathophysiologic mechanisms being persistent pulmonary vasoconstriction and irreversible vascular remodeling. The impact significantly affects the prognosis of patients with pulmonary hypertension. If it is not treated and intervened in time, it may lead to right ventricular failure and further endanger the patient's life. Within the past decade or so, nebulized inhalation therapy is considered to have advantages in the treatment of pulmonary hypertension as a safe, limited, and rapid therapy, for example, inhaled vasodilators (prostate analogs, nitroglycerin, carbon monoxide analogs sildenafil, and nitroprusside), inhaled anti-inflammatory and antiproliferative agents (simvastatin, and selatinib), and inhaled peroxides (levocetirizine) have been recognized as emerging therapeutic approaches in the treatment of pulmonary hypertension as emerging therapeutic approaches. Therefore, this article provides a brief review of recent advances in the potential of nebulized inhaled vasodilators, anti-inflammatory and antiproliferative agents, and anti-peroxides for the treatment of pulmonary hypertension, with the aim of providing different therapeutic options for the treatment of pulmonary hypertension, enhancing the quality of survival, alleviating symptoms, and improving the prognosis of patients with this condition., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)

Purpose: Electrospinning technology was used to construct PCL composite nanofiber scaffold material of BMP-2 sustained-release nanospheres, and the effect of this nanospheres on proliferation and differentiation of MC3T3-E1 cells was evaluated., Methods: Solvent removal method and electrostatic self-assembly technology were used to prepare BMP-2 loaded chitosan nanospheres, the morphology, particle size and composition, BMP-2 protein encapsulation efficiency, and in vitro sustained release were tested. Electrospinning technology was ued to prepare PCL composite scaffold material containing BMP-2 nanospheres, and its morphology, hydrophilicity,and sustained release of BMP-2 protein were examined. In vitro cytology experiment was conducted to observe the growth of cells in the material, and the formation of ALP, related genes, and mineralized nodules during the process of osteogenic differentiation of the material were detected. SPSS 21.0 software package was used for statistical analysis., Results: The nanospheres structure with stable structure was successfully prepared, with a high drug loading rate and sustained release of BMP-2. The PCL/BNPs scaffold material group had good hydrophilic properties and was conducive to cell proliferation and differentiation. The results of in vitro cell experiments showed that the cells spread well on the scaffold and the number of adhesions increased. ALP and related osteogenic genes COL1, OPN, RUNX2 increased, and the size and number of calcium nodules increased significantly., Conclusions: The polycaprolactone composite fiber scaffold material of BMP-2 sustained-release nanospheres can provide a new choice for the development of bone tissue engineering.